STOCK TITAN
  1. Home
  2. Sec-filings
  3. BIAFW
  4. [EFFECT] bioAffinity Technologies, Inc. Warrant SEC Filing

[EFFECT] bioAffinity Technologies, Inc. Warrant SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
Rhea-AI Filing Summary
Riscrivi il testo seguente:
Reescribe el siguiente texto:
다음 텍스트를 다시 작성하세요:
Réécrivez le texte suivant :
Schreibe den folgenden Text um:
Positive
  • None.
Negative
  • None.
Riscrivi il testo seguente:
Reescribe el siguiente texto:
다음 텍스트를 다시 작성하세요:
Réécrivez le texte suivant :
Schreibe den folgenden Text um:
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 3, 2025
Accession Number: 0001641172-25-016927
Submission Type: POS AM
CIK: 0001712762
Company Name: bioAffinity Technologies, Inc.
File Number: 333-283521

Source: View Original Filing on SEC EDGAR

Stock BIAFW logo
bioAffinity Tech

NASDAQ:BIAFW

BIAFW Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

BIAFW Latest News

Jul 9, 2025
Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient with Inconclusive Imaging
Jun 26, 2025
bioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA Therapeutics Conference
Jun 24, 2025
bioAffinity Technologies Expands Patent Portfolio with China Grant for siRNA-Based Cancer Therapy
Jun 11, 2025
bioAffinity Technologies President and CEO Maria Zannes Appointed to American Lung Association in Texas’ Leadership Board
Jun 3, 2025
bioAffinity Technologies Works With Cardinal Health™ OptiFreight® Logistics to Help Meet Demand for CyPath® Lung

BIAFW Latest SEC Filings

Jul 7, 2025
[EFFECT] bioAffinity Technologies, Inc. Warrant SEC Filing
Jun 27, 2025
[POS AM] bioAffinity Technologies, Inc. Warrant SEC Filing
Jun 27, 2025
[POS AM] bioAffinity Technologies, Inc. Warrant SEC Filing

BIAFW Stock Data

1.60M
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States
SAN ANTONIO